Ex-Arthrocare exec pleads guilty to stock fraud scheme

Ex-Arthrocare exec pleads guilty to stock fraud scheme

Ex-ArthroCare (NSDQ:ARTC) executive David Applegate pleaded guilty this week to federal charges that he helped run a scheme that eventually defrauded investors in the medical device company of some $400 million.

Applegate, 54, pleaded to 1 count of conspiracy to commit securities, mail & wire fraud and another count of making false statements, for regulatory filings made with the SEC containing faked quarterly and annual sales figures.

Applegate and another ex-ArthroCare exec, John Raffle, were arrested last summer and charged by the U.S. Justice Dept. with wire fraud and making false statements in connection with the alleged scheme to artificially inflate ArthroCare’s share price by rigging its sales figures, according to court documents.

The feds accused Applegate and Raffle of generating false revenue numbers designed to meet internal and external forecasts by dumping inventory, first with a distributor called DiscoCare and eventually via free shipments to end-users. ArthroCare was DiscoCare’s only client until it acquired DiscoCare in December 2007, according to the documents.

"Raffle, Applegate and others inflated falsely ArthroCare’s sales and revenue through a series of end-of-quarter transactions involving DiscoCare. After Raffle and Applegate determined the type and amount of product to be shipped to DiscoCare based on ArthroCare’s need to meet sales forecasts, rather than DiscoCare’s needs for the products, Raffle, Applegate and others caused ArthroCare to ship millions of dollars worth of ArthroCare’s medical devices to DiscoCare at the end of quarters. ArthroCare would then report these shipments as sales in its quarterly and annual filings at the time of the shipment, enabling the company to meet or exceed internal and external earnings forecasts," according to the documents.

From the 4th quarter of 2005 until the 4th quarter of 2007, ArthroCare shipped DiscoCare a total of roughly $37 million worth of products, court documents say, with DiscoCare paying less than $50,000 back to ArthroCare during that time.

But the scheme grew too big to cover using the DiscoCare ruse, so Applegate and Raffle allegedly engineered a buyout of the distributor.

"Because ArthroCare continued to ship to DiscoCare more product than there were patients who were actually undergoing surgery with the product, and because DiscoCare could not receive reimbursement from insurance companies for product that was not used during surgery, DiscoCare’s account receivable with ArthroCare began to grow dramatically. From June 2007 to December 2007, DiscoCare’s account receivable to ArthroCare more than doubled, to over $26 million," the documents allege. "To conceal the fact that DiscoCare owed ArthroCare a substantial amount of money on the unused inventory, Raffle and others, with Applegate’s knowledge, caused ArthroCare to acquire DiscoCare on December 31, 2007."

Raffle then allegedly cooked up another scheme to falsely inflate sales, called "Son of DRS," involving the shipment of medical devices from ArthroCare’s sports division to customers for free. ArthroCare would then invoice DiscoCare and record the shipments as revenue.

"Instead of parking inventory at the DiscoCare warehouse, Raffle and others, with Applegate’s knowledge, caused the inventory to be parked at end-users, while simultaneously invoicing DiscoCare," according to the documents. "DiscoCare did not know that it was being invoiced under the ‘Son of DRS’ program for millions and millions of dollars worth of ArthroCare products, and therefore, could not possibly have purchased the products. Between August and November 2007, Raffle and others, with Applegate’s knowledge, caused ArthroCare to falsely report over $7 million in revenue in its publicly filed financial statements based on purported sales to DiscoCare under this program."

Applegate faces a maximum sentence of 5 years in prison for the conspiracy charge and 20 years for the mail and wire fraud charge.

ArthroCare and the Justice Dept. have until the end of this month to hash out a deal over a criminal probe into the Austin, Texas-based company’s spinal business, having extended the deadline 3 times already. The deal was 1st extended in January and again the following month, until March 30.

ArthroCare president & CEO David Fitzgerald told investors during the J.P. Morgan Healthcare conference in San Francisco early this year that the DOJ could ask for an extension.

"The DOJ criminal investigation that began in December of 2008 is ongoing and we continue to actively cooperate with the investigation," Fitzgerald said at the time. "Although the DoJ has not committed to an end date and may request future tolling agreements, we think it’s possible that the DoJ investigation of the company may complete soon."

ArthroCare launched an internal investigation into the DiscoCare sales in July of 2008 and announced that it would restate previously reported financial earnings for the period from Q3 2006 to Q1 2008. The day that announcement was made, ARTC shares dropped from $40.03 to $23.21 per share, a loss of more than 40%.

Earlier this year ArthroCare lost a $74 million settlement to shareholders in a lawsuit accusing the company, former president & CEO Michael Baker and former senior VP and CFO Michael Gluk of making "public statements that were materially false and misleading" in order to inflate share prices.

RSS From Medical Design & Outsourcing

  • Saelig presents new Amplicon Impact-R 1100F series computer
    Saelig Company announces the Amplicon Impact-R 1100F series, a fanless system powered by the Intel ATOM D2550 processor. Configured with a high performance 2.5 in. MLC Solid State Drive (SSD), the Impact-R 1100F series is a silent controller system. With options for multiple serial communication ports, the Impact-R 1100F can offer up seven DB9 connections […]
  • Gerresheimer to acquire Centor
    Gerresheimer AG, a partner to the global pharmacy and healthcare industry, will further extend its pharmaceutical packaging business with the acquisition of Centor. Gerresheimer has reached an agreement with Nemera Development S.A. to acquire 100% of the share capital of Centor US Holding. “Centor is the highly profitable market leader for plastic vials and closures in […]
  • Methods Machine Tools presents the new Nakamura-Tome NTRX-300
    Methods Machine Tools, a developer of precision machine tools and automation, has introduced the new Nakamura-Tome NTRX-300, a multitasking turning center featuring complete parts machining in one operation, with a built-in load and unload automation system and advanced operator recognition management software. The NTRX-300 features true opposing twin spindles: an 8 in. A2-6 25 HP or […]
  • MSC Apex Diamond Python and Smart Midsurface speeds modeling to validation
    MSC Software announced a new release of MSC Apex, the company’s award-winning next generation Computer Aided Engineering (CAE) platform. The MSC Apex Diamond Python release introduces: · The fourth release of MSC Apex Modeler is a CAE Specific direct modeling and meshing solution that streamlines CAD clean-up, simplification and meshing workflow. New in this release is […]
  • Quality Metrics: FDA’s plan for a key set of measurements to help ensure manufacturers are producing quality medications
    Editor’s Note: This article is written by Ashley Boam and Mary Malarkey from the “FDA Voice” blog. Boam is an FDA’s acting Director of the Office of Policy for Pharmaceutical Quality, the Office of Pharmaceutical Quality and the Center for Drug Evaluation and Research. Malarkey is an FDA’s Director if the Office of Compliance and Biologics Quality […]
  • MasterControl’s CEO talks EQMS software and new partnerships
    MasterControl offers a quality and compliance software that helps device companies speed time to market and improve their bottom lines. Under Jon’s leadership, the company has blossomed into a market leader and has a unique corporate culture that fosters growth, excellence and quality. In this podcast, MasterControl’s CEO, Jon Beckstrand, will discuss electronic quality management […]
  • BIT Group launches white label IVD solutions
    BIT Group has launched a product line of customizable IVD white label instruments. During recent years, BIT has invested capital and resources developing customizable, ready-to-use IVD systems to address a growing demand. “The IVD market is challenging for our clients,” said Marius Balger, CEO at BIT. “OEM’s must adhere to a growing number of evolving IVD […]
  • Toshiba expands line-up of ARM Cortex-M-based microcontrollers
    Toshiba announced that it has enhanced its current “TX Family” of ARM core-based microcontrollers and started to develop three series of microcontrollers, “TXZ0 series,” “TXZ3 series” and “TXZ4 series,” as part of the “TXZTM Family.” The TXZTM Family is a new collection of flash microcontrollers that support low-power consumption and high-speed operation for IoT and M2M […]
  • Parker Hannifin consolidates, layoffs ahead
    Parker Hannifin plans to consolidate a number of internal divisions, close 2 facilities and expand its Mexican operations, according to an internally distributed letter from Andy Ross, Parker’s engineered materials group president. The company has confirmed the letter was authentic, but has not disclosed how many employees will be affected by the new plans or […]
  • 3-phase current transducer from PEM delivers all-in-one convenience
    The new RCTrms 3-ph current transducer from Power Electronic Measurements (PEM) delivers a convenient, safe and accurate solution for measuring current in three phases. It features a thin, clip-around, flexible sensor coil and provides accurate true rms measurement with 4-20 mA or 0-5 V output, enabling simple installation with PLC’s, SCADA systems or automation equipment. […]
  • Safety alert: Recall on two IV solutions from Baxter
    Baxter International announced it is voluntarily recalling two lots of intravenous (IV) solutions to the hospital and user level due to the potential presence of particulate matter. The particulate matter in each case was determined to be an insect and was identified as a result of a customer complaint. The matter was identified prior to […]

Leave a Reply